New therapeutic approach for the treatment of sarcoidosis

by Medical University of ViennaImmunofluorescence staining makes granulomas glow red with a green border (macrophages with fibroblasts). Credit: MedUni Vienna/Anna RedlA research team led by Geor

Updated on: April 02,2024 13

New therapeutic approach for the treatment of sarcoidosis

by Medical University of ViennaImmunofluorescence staining makes granulomas glow red with a green border (macrophages with fibroblasts). Credit: MedUni Vienna/Anna RedlA research team led by Geor

Updated on:April 02,2024 13

Liver cancer study encourages caution with certain gene therapies

bySanford Burnham Prebys Medical Discovery InstituteGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.10.004Research led by Randal J. Kaufman, Ph.D., has

Updated on: December 22,2023 8

Liver cancer study encourages caution with certain gene therapies

bySanford Burnham Prebys Medical Discovery InstituteGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.10.004Research led by Randal J. Kaufman, Ph.D., has

Updated on:December 22,2023 8

Diabetes complications worsen prognosis for colorectal cancer patients

Complications of diabetes can have numerous negative health effects, from impaired vision and nerve damage to kidney dysfunction and heart disease. In an analysis of information on adults with colorec

Updated on: October 30,2023 15

Diabetes complications worsen prognosis for colorectal cancer patients

Complications of diabetes can have numerous negative health effects, from impaired vision and nerve damage to kidney dysfunction and heart disease. In an analysis of information on adults with colorec

Updated on:October 30,2023 15

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on: December 22,2023 10

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on:December 22,2023 10

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&

Updated on: December 18,2023 6

Cancer screening and detection remain below prepandemic levels

At the end of 2021, population-based screening and diagnosis remained below prepandemic levels for breast, cervical, and colorectal cancers, according to a research letter published online Nov. 17 in&

Updated on:December 18,2023 6

The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

byBrigham and Women's HospitalA double stranded DNA fragment. Credit: Vcpmartin/Wikimedia/ CC BY-SA 4.0Oropharynx cancers caused by human papillomavirus (HPV) have risen dramatically over th

Updated on: January 04,2024 8

The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

byBrigham and Women's HospitalA double stranded DNA fragment. Credit: Vcpmartin/Wikimedia/ CC BY-SA 4.0Oropharynx cancers caused by human papillomavirus (HPV) have risen dramatically over th

Updated on:January 04,2024 8

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph

Updated on: October 21,2024 0

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph

Updated on:October 21,2024 0

Radiation therapy outcomes better for African-American than Caucasian prostate cancer patients

byAmerican Society for Radiation OncologyWhile popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new an

Updated on: December 18,2023 15

Radiation therapy outcomes better for African-American than Caucasian prostate cancer patients

byAmerican Society for Radiation OncologyWhile popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new an

Updated on:December 18,2023 15

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t

Updated on: December 18,2023 16

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t

Updated on:December 18,2023 16

Study reviews the role of a ribonucleic acid 'MALAT1' in hematological malignancies

by Cactus CommunicationsRecent studies have shown that an abnormally high expression of MALAT1 in blood cancer cells could aid the chemotherapeutic resistance development through multiple intermolecul

Updated on: April 28,2024 0

Study reviews the role of a ribonucleic acid 'MALAT1' in hematological malignancies

by Cactus CommunicationsRecent studies have shown that an abnormally high expression of MALAT1 in blood cancer cells could aid the chemotherapeutic resistance development through multiple intermolecul

Updated on:April 28,2024 0

Consumer health: What is lung cancer screening, and who needs it?

by Laurel KellyCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. Lung cancer claims more lives each year than co

Updated on: December 18,2023 19

Consumer health: What is lung cancer screening, and who needs it?

by Laurel KellyCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. Lung cancer claims more lives each year than co

Updated on:December 18,2023 19

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t

Updated on: December 18,2023 10

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t

Updated on:December 18,2023 10